12:00 AM
Sep 28, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Human neural stem cells: IND approved

Neuralstem said FDA approved its IND for a U.S. Phase I trial to evaluate its human neural stem cells in 18 patients. The company hopes to start the trial by year end. The first stage of the trial will enroll 12...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >